Companies › EYPT

EYEPOINT INC COM NEW (EYPT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001314102 · EDGAR filings · Updated 2026-07-28

EYEPOINT INC COM NEW (EYPT) has reported institutional ownership of 105.7%, with 187 institutional managers holding positions valued at $1.14B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (3)

• 2026-07-28 — SCHEDULE 13G/A filed
• 2026-07-22 — 144/A filed
• 2026-07-22 — 144/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — Notice of proposed sale filed (Form 144)
• 2026-07-17 — Current report (8-K) filed
• 2026-07-14 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, EYEPOINT INC COM NEW has 187 institutional holders and institutional ownership of 105.7%.

Insider activity

Insiders reported 47 transactions (5 buys, 8 sells) across 6 reporting insiders, with a net reported value of −$1.80M.

Data flags from SEC filings

Related companies

MOONLAKE IMMUNOTHERAPEUTICS (MLTX) · SAVARA INC (SVRA) · GENERATE BIOMEDICINES INC (GENB) · PHIBRO ANIMAL HEALTH CORP (PAHC) · SEPTERNA INC (SEPN) · ZENAS BIOPHARMA INC (ZBIO)